MTORC1-Regulated Metabolism Controlled by TSC2 Limits Cardiac Reperfusion Injury.

Rationale: The mechanistic target of rapamycin complex-1 (mTORC1) controls metabolism and protein homeostasis, and is activated following ischemic reperfusion (IR) injury and by ischemic preconditioning (IPC). However, studies vary as to whether this activation is beneficial or detrimental, and its influence on metabolism after IR is little studied. A limitation of prior investigations is their use of broad gain/loss of mTORC1 function, mostly applied prior to ischemic stress. This can be circumvented by regulating one serine (S1365) on tuberous sclerosis complex (TSC2) to achieve bi-directional mTORC1 modulation but only with TCS2-regulated co-stimulation. Objective: We tested the hypothesis that reduced TSC2 S1365 phosphorylation protects the myocardium against IR and IPC by amplifying mTORC1 activity to favor glycolytic metabolism. Methods and Results: Mice with either S1365A (TSC2SA; phospho-null) or S1365E (TSC2SE; phosphomimetic) knock-in mutations were studied ex vivo and in vivo. In response to IR, hearts from TSC2SA mice had amplified mTORC1 activation and improved heart function compared to WT and TSC2SE hearts. The magnitude of protection matched IPC. IPC requited less S1365 phosphorylation, as TSC2SE hearts gained no benefit and failed to activate mTORC1 with IPC. IR metabolism was altered in TSC2SA, with increased mitochondrial oxygen consumption rate and glycolytic capacity (stressed/maximal extracellular acidification) after myocyte hypoxia-reperfusion. In whole heart, lactate increased and long-chain acyl-carnitine levels declined during ischemia. The relative IR protection in TSC2SA was lost by lowering glucose in the perfusate by 36%. Adding fatty acid (palmitate) compensated for reduced glucose in WT and TSC2SE but not TSC2SA which had the worst post-IR function under these conditions. Conclusions: TSC2-S1365 phosphorylation status regulates myocardial substrate utilization, and its decline activates mTORC1 biasing metabolism away from fatty acid oxidation to glycolysis to confer protection against IR. This pathway is also engaged and reduced TSC2 S1365 phosphorylation required for effective IPC.

[1]  Dong I. Lee,et al.  PKG1α Cysteine-42 Redox State Controls mTORC1 Activation in Pathological Cardiac Hypertrophy , 2020, Circulation research.

[2]  L. Bertrand,et al.  Cardiac metabolism as a driver and therapeutic target of myocardial infarction , 2020, Journal of cellular and molecular medicine.

[3]  Nicola Zamboni,et al.  Lipid signalling drives proteolytic rewiring of mitochondria by YME1L , 2019, Nature.

[4]  J. Roose,et al.  mTOR and other effector kinase signals that impact T cell function and activity , 2019, Immunological reviews.

[5]  Yulin Chang,et al.  Propofol can suppress renal ischemia-reperfusion injury through the activation of PI3K/AKT/mTOR signal pathway. , 2019, Gene.

[6]  B. Manning,et al.  Molecular logic of mTORC1 signalling as a metabolic rheostat , 2019, Nature Metabolism.

[7]  Dong I. Lee,et al.  Chronic Atrial and Ventricular Pacing in the Mouse: Application to Model Cardiac Dyssynchrony and Resynchronization in Heart Failure , 2019, Circulation. Heart failure.

[8]  Dong Ik Lee,et al.  PKG-Modified TSC2 Regulates mTORC1 Activity to Counter Adverse Cardiac Stress , 2018, Nature.

[9]  S. Biswal,et al.  S-Nitrosoglutathione Reductase Is Essential for Protecting the Female Heart From Ischemia-Reperfusion Injury , 2018, Circulation research.

[10]  Hong Jiang,et al.  Inhibition of autophagy via activation of PI3K/Akt/mTOR pathway contributes to the protection of hesperidin against myocardial ischemia/reperfusion injury , 2018, International journal of molecular medicine.

[11]  Weifeng Huang,et al.  Puerarin protects rat brain against ischemia/reperfusion injury by suppressing autophagy via the AMPK-mTOR-ULK1 signaling pathway , 2018, Neural regeneration research.

[12]  J. Sadoshima,et al.  New Insights Into the Role of mTOR Signaling in the Cardiovascular System. , 2018, Circulation Research.

[13]  Xin Ma,et al.  Mammalian target of rapamycin inhibition attenuates myocardial ischaemia–reperfusion injury in hypertrophic heart , 2018, Journal of cellular and molecular medicine.

[14]  D. Sabatini,et al.  mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.

[15]  K. Tārs,et al.  Long-chain acylcarnitines determine ischaemia/reperfusion-induced damage in heart mitochondria. , 2016, The Biochemical journal.

[16]  J. Inserte,et al.  The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism , 2015, British journal of pharmacology.

[17]  Anindita Das,et al.  PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer. , 2015, Pharmacology & therapeutics.

[18]  Thomas Danner,et al.  Phosphodiesterase 9A Controls Nitric-oxide Independent cGMP and Hypertrophic Heart Disease , 2015, Nature.

[19]  Jonathan D. Powell,et al.  Integrating canonical and metabolic signalling programmes in the regulation of T cell responses , 2014, Nature Reviews Immunology.

[20]  F. Sellke,et al.  Rapamycin treatment of healthy pigs subjected to acute myocardial ischemia-reperfusion injury attenuates cardiac functions and increases myocardial necrosis. , 2014, The Annals of thoracic surgery.

[21]  Cheng-Tien Wu,et al.  Protective Role of AMP-Activated Protein Kinase-Evoked Autophagy on an In Vitro Model of Ischemia/Reperfusion-Induced Renal Tubular Cell Injury , 2013, PloS one.

[22]  Anindita Das,et al.  Rapamycin protects against myocardial ischemia-reperfusion injury through JAK2-STAT3 signaling pathway. , 2012, Journal of molecular and cellular cardiology.

[23]  Masaya Takahashi,et al.  Cardiac mTOR protects the heart against ischemia-reperfusion injury. , 2012, American journal of physiology. Heart and circulatory physiology.

[24]  Anindita Das,et al.  Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection. , 2012, Journal of the American College of Cardiology.

[25]  Robert A. Harris,et al.  Stimulation of glucose oxidation protects against acute myocardial infarction and reperfusion injury. , 2012, Cardiovascular research.

[26]  JunichiSadoshima,et al.  Differential Roles of GSK-3β During Myocardial Ischemia and Ischemia/Reperfusion , 2011 .

[27]  Anne E Carpenter,et al.  mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway , 2011, Cell.

[28]  F. Vigneron,et al.  GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways. , 2011, Cardiovascular research.

[29]  A. Abbate,et al.  Phosphodiesterase-5 Inhibitor, Tadalafil, Protects Against Myocardial Ischemia/Reperfusion Through Protein-Kinase G–Dependent Generation of Hydrogen Sulfide , 2009, Circulation.

[30]  V. Mootha,et al.  mTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex , 2007, Nature.

[31]  T. Asano,et al.  Distinct Roles of Autophagy in the Heart During Ischemia and Reperfusion: Roles of AMP-Activated Protein Kinase and Beclin 1 in Mediating Autophagy , 2007, Circulation research.

[32]  G. Vetrovec,et al.  Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes. , 2006, Journal of molecular and cellular cardiology.

[33]  S. Lloyd,et al.  Impact of High Glucose/High Insulin and Dichloroacetate Treatment on Carbohydrate Oxidation and Functional Recovery After Low-Flow Ischemia and Reperfusion in the Isolated Perfused Rat Heart , 2005, Circulation.

[34]  Steven P Gygi,et al.  Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  K. Inoki,et al.  TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival , 2003, Cell.

[36]  F. Salloum,et al.  Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits. , 2002, American journal of physiology. Heart and circulatory physiology.

[37]  D. Yellon,et al.  Myocardial Protection by Insulin at Reperfusion Requires Early Administration and Is Mediated via Akt and p70s6 Kinase Cell-Survival Signaling , 2001, Circulation research.

[38]  B. Griffith,et al.  Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase. , 2000, Circulation.

[39]  R. Lerch,et al.  Substrate competition in postischemic myocardium. Effect of substrate availability during reperfusion on metabolic and contractile recovery in isolated rat hearts. , 1994, Circulation research.